| scholarly article | Q13442814 |
| P50 | author | Jwu Jin Khong | Q50797300 |
| Jamie E Craig | Q82048083 | ||
| P2093 | author name string | Peter R Ebeling | |
| Dinesh Selva | |||
| Alan A McNab | |||
| P2860 | cites work | Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis | Q24301803 |
| Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity | Q26852013 | ||
| Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. | Q27691806 | ||
| Selenium and the course of mild Graves' orbitopathy | Q28238021 | ||
| Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. | Q34130987 | ||
| A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor | Q34622464 | ||
| A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. | Q34782210 | ||
| Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts | Q34998187 | ||
| Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study. | Q35055076 | ||
| Randomized controlled trial of rituximab in patients with Graves' orbitopathy | Q35055124 | ||
| Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA | Q35153361 | ||
| Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes | Q35792099 | ||
| Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor | Q35992560 | ||
| Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt | Q36069781 | ||
| Insight into Graves' hyperthyroidism from animal models | Q36096738 | ||
| Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB. | Q36422528 | ||
| Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment | Q36525240 | ||
| Cigarette smoking and thyroid eye disease: a systematic review | Q36596473 | ||
| A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy | Q36817224 | ||
| Clinical review: Clinical utility of TSH receptor antibodies | Q36885833 | ||
| Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies | Q36970632 | ||
| Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy. | Q37017174 | ||
| Immune mechanisms in thyroid eye disease. | Q37254482 | ||
| Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype | Q37296579 | ||
| The type 1 insulin-like growth factor receptor pathway | Q37300867 | ||
| Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. | Q37363607 | ||
| Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. | Q37417167 | ||
| A modified ELISA accurately measures secretion of high molecular weight hyaluronan (HA) by Graves' disease orbital cells | Q37479329 | ||
| Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy | Q37515485 | ||
| Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease. | Q38013212 | ||
| Immunotherapy for Graves' ophthalmopathy | Q38238204 | ||
| Transcriptome-level microarray expression profiling implicates IGF-1 and Wnt signalling dysregulation in the pathogenesis of thyroid-associated orbitopathy | Q38325670 | ||
| Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. | Q38351966 | ||
| Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease | Q39167512 | ||
| Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy | Q40893670 | ||
| Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite | Q40917292 | ||
| Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO). | Q41096678 | ||
| The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes | Q42801077 | ||
| Increased oxidative DNA damage, lipid peroxidation, and reactive oxygen species in cultured orbital fibroblasts from patients with Graves' ophthalmopathy: evidence that oxidative stress has a role in this disorder | Q43124440 | ||
| A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. | Q43125924 | ||
| Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study | Q43626915 | ||
| Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy | Q43804248 | ||
| Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts | Q43845891 | ||
| Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes | Q43867818 | ||
| Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation | Q44356261 | ||
| Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis | Q44375662 | ||
| Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo | Q44468299 | ||
| Peripheral parameters of oxidative stress in Graves' disease: the effects of methimazole and 131 iodine treatments | Q44550002 | ||
| Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy | Q44582494 | ||
| Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. | Q45096631 | ||
| Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy. | Q45149782 | ||
| Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy | Q45192863 | ||
| Potential utility of rituximab for Graves' orbitopathy | Q45719549 | ||
| IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy. | Q45981776 | ||
| Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway | Q46107628 | ||
| Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy | Q46113795 | ||
| Oxidative stress in patients with Graves' ophthalmopathy: relationship between oxidative DNA damage and clinical evolution. | Q46320003 | ||
| Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy | Q46527993 | ||
| Autoantibodies to the IGF1 receptor in Graves' orbitopathy | Q46825815 | ||
| Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist | Q47321532 | ||
| Analysis of orbital T cells in thyroid-associated ophthalmopathy | Q47901537 | ||
| Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center. | Q51258119 | ||
| Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy. | Q53092953 | ||
| Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy. | Q53611171 | ||
| Smoking and Risk of Graves' Disease | Q54186495 | ||
| Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy. | Q54280456 | ||
| The expression of intercellular adhesion molecule-1 induced by CD40-CD40L ligand signaling in orbital fibroblasts in patients with Graves' ophthalmopathy. | Q54444573 | ||
| Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism | Q57482592 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 142-150 | |
| P577 | publication date | 2015-11-13 | |
| P1433 | published in | British Journal of Ophthalmology | Q13443571 |
| P1476 | title | Pathogenesis of thyroid eye disease: review and update on molecular mechanisms | |
| P478 | volume | 100 |
| Q92994581 | A Novel Method of CT Exophthalmometry in Patients With Thyroid Eye Disease |
| Q47299466 | A genome-wide DNA methylation analysis in peripheral blood from patients identifies risk loci associated with Graves' orbitopathy |
| Q64285170 | Bioinformatic Analysis Identifies Potentially Key Differentially Expressed Genes and Pathways in Orbital Adipose Tissues of Patients with Thyroid Eye Disease |
| Q53065936 | Choroidal Thickness in Patients with Graves' Ophthalmopathy. |
| Q37010019 | Cigarette Smoke Extract-Induced Oxidative Stress and Fibrosis-Related Genes Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy |
| Q63387333 | Clinical pathophysiology of thyroid eye disease: The Cone Model |
| Q55717336 | Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy. |
| Q40095263 | Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management |
| Q92088550 | Efficacy and safety of tripterygium glycosides for Graves ophthalmopathy: A systematic review and meta-analysis |
| Q94474152 | Enhanced orbital adipogenesis in a mouse model of T-cell-mediated autoimmunity, zymosan A-treated SKG mice: Implications for Graves' ophthalmopathy |
| Q54960708 | Essential role of connective tissue growth factor (CTGF) in transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation from Graves' orbital fibroblasts. |
| Q90185484 | Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy |
| Q58767088 | Long-term effect of triamcinolone acetonide in the treatment of upper lid retraction with thyroid associated ophthalmopathy |
| Q47323119 | Measurement of Orbital Biomechanical Properties in Patients with Thyroid Orbitopathy Using the Dynamic Scheimpflug Analyzer (Corvis ST). |
| Q99579021 | MicroRNA-146a downregulates the production of hyaluronic acid and collagen I in Graves' ophthalmopathy orbital fibroblasts |
| Q38680245 | Piezosurgery in modified pterional orbital decompression surgery in Graves' disease |
| Q47121440 | RNA-Sequencing Gene Expression Profiling of Orbital Adipose-Derived Stem Cell Population Implicate HOX Genes and WNT Signaling Dysregulation in the Pathogenesis of Thyroid-Associated Orbitopathy |
| Q38986592 | Roles of IL-6 in Ocular Inflammation: A Review |
| Q92157970 | The role of cell mediated immunopathogenesis in thyroid-associated ophthalmopathy |
| Q55140443 | Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future. |
| Q88139077 | [Calculation of orbital fat volumes for determining treatment timing for thyroid- associated ophthalmopathy] |
Search more.